MASIMO CORP (MASI)
Clinical trial NCT06232876 updates: 1. start date: 2025-11-01 → 2026-06-01 2. completion date: 2026-11-01 → 2029-03-01 3. primary completion date: 2026-11-01 → 2028-07-01 4. enrollment: not set → 492 participants
Clinical trial NCT06232876 updates: 1. start date: 2025-11-01 → 2026-06-01 2. completion date: 2026-11-01 → 2029-03-01 3. primary completion date: 2026-11-01 → 2028-07-01 4. enrollment: not set → 492 participants
📉 **NEGATIVE** • Low confidence analysis (54%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (45%) **Content type:** Clinical